Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-09 Purchase | 2025-06-10 5:26 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 100,000 | $0.7008 | $70,080 | 1,079,891 (Indirect Direct) | View |
| 2025-06-06 Purchase | 2025-06-10 5:23 pm | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 20,000 | $0.576 | $11,520 | 81,983 (Indirect Direct) | View |
| 2025-06-06 Purchase | 2025-06-10 5:22 pm | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 40,010 | $0.637 | $25,486 | 80,010 (Direct) | View |
| 2023-02-21 Purchase | 2023-02-21 8:05 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,823 | $0.8415 | $4,900 | 979,891 (Indirect Direct) | View |
| 2023-02-13 Purchase | 2023-02-13 4:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,606 | $0.8742 | $4,901 | 974,068 (Indirect Direct) | View |
| 2023-02-06 Purchase | 2023-02-06 4:03 pm | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 5,040 | $0.9723 | $4,900 | 968,462 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-12 Option Award | 2025-06-12 5:30 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | Pasternak Andy Director | 138,900 | $0 | 138,900 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 5:28 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director | 123,500 | $0 | 123,500 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 5:27 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | Smith Karen L. Director | 123,500 | $0 | 123,500 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 5:25 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director | 123,500 | $0 | 123,500 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 5:24 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | Walker Luke Nathaniel Director | 123,500 | $0 | 123,500 (Direct) | View |
| 2025-06-12 Option Award | 2025-06-12 5:23 pm | N/A 2035-06-11 | Context Therapeutics Inc. | CNTX | West Linda Director | 123,500 | $0 | 123,500 (Direct) | View |
| 2025-06-09 Option Award | 2025-06-09 5:22 pm | N/A 2035-06-08 | Context Therapeutics Inc. | CNTX | Chagin Karen Deborah Chief Medical Officer | 153,000 | $0 | 153,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-14 4:13 pm | N/A 2035-02-12 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 371,800 | $0 | 371,800 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-14 4:11 pm | N/A 2035-02-12 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 349,900 | $0 | 349,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-14 4:07 pm | N/A 2035-02-12 | Context Therapeutics Inc. | CNTX | Dansky Ullmann Claudio Chief Medical Officer | 174,960 | $0 | 174,960 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-14 4:06 pm | N/A 2035-02-12 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 802,700 | $0 | 802,700 (Direct) | View |
| 2025-01-13 Option Award | 2025-01-14 8:43 pm | N/A 2035-01-12 | Context Therapeutics Inc. | CNTX | Pasternak Andy Director | 20,685 | $0 | 20,685 (Direct) | View |
| 2024-09-04 Option Award | 2024-09-05 08:15 am | N/A 2034-09-03 | Context Therapeutics Inc. | CNTX | Smith Karen L. Director | 19,315 | $0 | 19,315 (Direct) | View |
| 2024-09-04 Option Award | 2024-09-05 08:04 am | N/A 2034-09-03 | Context Therapeutics Inc. | CNTX | Walker Luke Nathaniel Director | 19,315 | $0 | 19,315 (Direct) | View |
| 2024-08-01 Option Award | 2024-08-01 5:18 pm | N/A 2034-07-31 | Context Therapeutics Inc. | CNTX | Dansky Ullmann Claudio Chief Medical Officer | 202,170 | $0 | 202,170 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 07:52 am | N/A 2034-06-12 | Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 07:50 am | N/A 2034-06-12 | Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 07:47 am | N/A 2034-06-12 | Context Therapeutics Inc. | CNTX | West Linda Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 07:41 am | N/A 2034-06-12 | Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-22 08:04 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 160,115 | $0 | 160,115 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-22 08:01 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 153,515 | $0 | 153,515 (Direct) | View |
| 2024-03-21 Option Award | 2024-03-22 08:01 am | N/A 2034-03-20 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 291,402 | $0 | 291,402 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | Kantoff Philip W. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | West Linda Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:53 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | Stacey Jennifer Evans Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-05-31 4:52 pm | N/A 2033-05-30 | Context Therapeutics Inc. | CNTX | BERMAN RICHARD J Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Levit Alex C. Chief Legal Officer, Corp. Sec | 151,505 | $0 | 151,505 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Lehr Martin A. Chief Executive Officer | 287,544 | $0 | 287,544 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-14 5:04 pm | N/A 2033-02-12 | Context Therapeutics Inc. | CNTX | Minai-Azary Jennifer Lynn Chief Financial Officer | 158,001 | $0 | 158,001 (Direct) | View |